Search Browse Earnings

Enveric Biosciences, Inc. — SlamSEC

Enveric Biosciences, Inc.

Nasdaq:ENVB

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$43.0M

-11.5% YoY

FY 2019

Adj. EBITDA

-$16.1M

-37.5% margin

FY 2024

Net Income

-$17.3M

-40.2% margin

FY 2024

EPS (Diluted)

-$121.29

FY 2024

Stock Price

$1.88

-4.6%

2026-03-09

52W Range

$1.90 – $22.20

P/E Ratio

-0.0x

Market Cap

$1.1M

Cash

$1.4M

FY 2019

Total Debt

$6.3M

FY 2018

Net Debt

$5.0M

FY 2018

Enterprise Value

$6.1M

Debt / EBITDA

-0.3x

FY 2019

EV / EBITDA

-0.4x

Employees

—